Xenotransplantation of microencapsulated human wharton jelly-derived adult mesenchymal stem cells (HUCMS) into overtly diabetic NOD mice

Riccardo Calafiore(University of Perugia), Giuseppina Basta(Istituto di Fisiologia Clinica), Marco Cavallo(Istituto Ortopedico Rizzoli), Sara Parrettini(University of Perugia), Teresa Pescara(University of Perugia), Pia Montanucci(University of Perugia), Bini
Unknown
January 1, 2017
Cited by 0

Related Papers

Cell encapsulation: Promise and progress
|Nature Medicine|2003|592
History, challenges and perspectives of cell microencapsulation
|Trends in biotechnology|2003|346
Microencapsulated Pancreatic Islet Allografts Into Nonimmunosuppressed Patients With Type 1 Diabetes
|Diabetes Care|2006|321
Mesenchymal Stem Cells Reduce Colitis in Mice via Release of TSG6, Independently of Their Localization to the Intestine
|Gastroenterology|2015|256
Long-Term Metabolic and Immunological Follow-Up of Nonimmunosuppressed Patients With Type 1 Diabetes Treated With Microencapsulated Islet Allografts
|Diabetes Care|2011|230